BCAL Diagnostics 過去の業績
過去 基準チェック /06
BCAL Diagnostics's earnings have been declining at an average annual rate of -44.4%, while the Biotechs industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 55% per year.
主要情報
-44.4%
収益成長率
-34.1%
EPS成長率
| Biotechs 業界の成長 | 9.6% |
| 収益成長率 | 55.0% |
| 株主資本利益率 | -74.5% |
| ネット・マージン | -206.6% |
| 前回の決算情報 | 30 Jun 2024 |
収支内訳
BCAL Diagnostics の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 3 | -6 | 4 | 4 |
| 31 Mar 24 | 3 | -6 | 4 | 4 |
| 31 Dec 23 | 4 | -5 | 4 | 4 |
| 30 Sep 23 | 3 | -5 | 3 | 4 |
| 30 Jun 23 | 3 | -5 | 3 | 4 |
| 31 Mar 23 | 2 | -5 | 3 | 4 |
| 31 Dec 22 | 1 | -5 | 2 | 3 |
| 30 Sep 22 | 1 | -4 | 2 | 3 |
| 30 Jun 22 | 1 | -3 | 2 | 2 |
| 31 Mar 22 | 1 | -3 | 1 | 2 |
| 31 Dec 21 | 1 | -3 | 1 | 2 |
| 30 Sep 21 | 0 | -2 | 1 | 1 |
| 30 Jun 21 | 0 | -2 | 1 | 1 |
| 31 Mar 21 | 0 | -1 | 1 | 0 |
| 31 Dec 20 | 1 | 0 | 1 | 0 |
| 30 Sep 20 | 0 | -1 | 1 | 0 |
| 30 Jun 20 | 0 | -1 | 1 | 0 |
| 30 Jun 19 | 0 | 0 | 0 | 0 |
| 30 Jun 18 | 0 | 0 | 0 | 0 |
質の高い収益: BDX is currently unprofitable.
利益率の向上: BDX is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: BDX is unprofitable, and losses have increased over the past 5 years at a rate of 44.4% per year.
成長の加速: Unable to compare BDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: BDX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (2.5%).
株主資本利益率
高いROE: BDX has a negative Return on Equity (-74.52%), as it is currently unprofitable.